Part I 1 Introduction Lucio G. Costa and David L. Eaton University of Washington, Seattle, WA

First Page		Document Content
Date: 2007-10-05 21:40:58 Population genetics Molecular biology Genomics Human genetics Single-nucleotide polymorphism Human genome Pharmacogenetics Gene–environment interaction Genetic variation Biology Genetics Philosophy of biology		Part I 1 Introduction Lucio G. Costa and David L. Eaton University of Washington, Seattle, WA Add to Reading List Source URL: media.wiley.com Download Document from Source Website File Size: 37,80 KB Share Document on Facebook

	Brad Hammoor Biochem 158 Professor Brutlag The Future of FDA Regulation of Pharmacogenetics DocID: 1vlX3 - View Document
	Sydney Beache Human Biology 158G The Economic, Ethical, and Social Implications of the Pharmacogenomics Movement I. Introduction to Pharmacogenomics While the term “pharmacogenetics” has been in existence for roughly DocID: 1u9i0 - View Document
	Privacy in Pharmacogenetics: An End-to-End Case Study of Personalized Warfarin Dosing Matthew Fredrikson∗ , Eric Lantz∗ , Somesh Jha∗ , Simon Lin† , David Page∗ , Thomas Ristenpart∗ University of Wisconsin∗ DocID: 1tI4M - View Document
	PharmacoGenetics-Pharmarmaconomics.ru № 2, 2017 Ôàðìàêîãåíåòèêà è Ôàðìàêîãåíîìèêà DocID: 1tDea - View Document
	Privacy in Pharmacogenetics: An End-to-End Case Study of Personalized Warfarin Dosing Matthew Fredrikson, Eric Lantz, and Somesh Jha, University of Wisconsin—Madison; Simon Lin, Marshfield Clinic Research Foundation; D DocID: 1sqsf - View Document